Device Cardiovascular Products

Terumo Advanced Perfusion System 1

Payments companies reported to CMS as associated with Terumo Advanced Perfusion System 1. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2,733associated payments (2023-2025)
58clinicians with associated payments
2companies reporting

By year

2023 $1,417
2024 $418
2025 $897

Payments reported as associated with Terumo Advanced Perfusion System 1, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,118
Physician Assistant $595
Surgical $480
Vascular Surgery $166
Anesthesiology $80.08
Neuroradiology $54.93

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Terumo Advanced Perfusion System 1

These are the largest totals companies reported as associated with Terumo Advanced Perfusion System 1. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Vasant Jayasankar Pensacola, FL Thoracic Surgery (Cardiothoracic Vascular Surgery) $221.36
Lindsey Saint Springfield, IL Thoracic Surgery (Cardiothoracic Vascular Surgery) $150.00
John Markley Columbia, MO Thoracic Surgery (Cardiothoracic Vascular Surgery) $150.00
Richard Schmaltz Columbia, MO Vascular Surgery $150.00
Christopher Heid Dallas, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $112.15
Michael Wait Dallas, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $112.15
Kristen Beheler Anderson, SC Surgical $100.26
Roger Andrews Eau Claire, WI Physician Assistant $98.41
Kirsten Montray Minneapolis, MN Surgical $98.41
Patrick Losito Buffalo, NY Surgical $71.79

Prescribed Terumo Advanced Perfusion System 1?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.